Hi-Clearance Inc. (TPEX:1788)
134.50
+0.50 (0.37%)
May 29, 2026, 1:30 PM CST
Hi-Clearance Revenue
Hi-Clearance had revenue of 1.15B TWD in the quarter ending March 31, 2026, with 9.01% growth. This brings the company's revenue in the last twelve months to 4.37B, up 5.16% year-over-year. In the year 2025, Hi-Clearance had annual revenue of 4.28B with 5.04% growth.
Revenue (ttm)
4.37B
Revenue Growth
+5.16%
P/S Ratio
1.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.28B | 205.42M | 5.04% |
| Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
| Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
| Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
| Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.85B |
| TaiDoc Technology | 4.30B |
| Wellell | 2.43B |
| OK Biotech | 1.53B |
| Dynamic Medical Technologies | 1.38B |
| WeLeader Biomedical | 1.14B |
| A Plus Biotechnology | 858.89M |
| Medimaging Integrated Solution | 675.15M |